Literature DB >> 2473558

Unraveling prion diseases through molecular genetics.

D Westaway, G A Carlson, S B Prusiner.   

Abstract

Prions are transmissible pathogens that cause degenerative diseases in humans and animals. Unique attributes of prion diseases include infectious, sporadic and genetic manifestations, as well as progression to death, all in the absence of a detectable immune response. Prions are resistant to chemical procedures that modify or destroy nucleic acids and are composed largely of a protein, designated PrPSc. Molecular cloning of a cognate cDNA established a cellular host origin for PrPSc protein and a convergence with the genetics of host susceptibility. The murine PrP gene is linked to the Prn-i gene which determines incubation times in experimental scrapie. Mice with long incubation times have unusual PrP alleles encoding phenylalanine and valine at codons 108 and 189. Moreover, the ataxic form of Gerstmann-Sträussler syndrome (a rare human neurodegenerative disorder) has been defined as an autosomal dominant disorder with a PrP mis-sense mutation at codon 102 linked to the predisposition locus. These studies argue that amino acid substitutions in 'PrP' genes may modulate initiation and development of prion diseases.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2473558     DOI: 10.1016/0166-2236(89)90126-4

Source DB:  PubMed          Journal:  Trends Neurosci        ISSN: 0166-2236            Impact factor:   13.837


  13 in total

1.  Presymptomatic detection or exclusion of prion protein gene defects in families with inherited prion diseases.

Authors:  J Collinge; M Poulter; M B Davis; M Baraitser; F Owen; T J Crow; A E Harding
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

Review 2.  Prion liposomes.

Authors:  R Gabizon; S B Prusiner
Journal:  Biochem J       Date:  1990-02-15       Impact factor: 3.857

Review 3.  Physicochemical properties of cells and their effects on intrinsically disordered proteins (IDPs).

Authors:  Francois-Xavier Theillet; Andres Binolfi; Tamara Frembgen-Kesner; Karan Hingorani; Mohona Sarkar; Ciara Kyne; Conggang Li; Peter B Crowley; Lila Gierasch; Gary J Pielak; Adrian H Elcock; Anne Gershenson; Philipp Selenko
Journal:  Chem Rev       Date:  2014-06-05       Impact factor: 60.622

Review 4.  The molecular mechanisms of scrapie encephalopathy and relevance to human neurodegenerative disease.

Authors:  W J Lukiw; H J Cho; J C Kaufmann; D R Crapper McLachlan
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

5.  Three hamster species with different scrapie incubation times and neuropathological features encode distinct prion proteins.

Authors:  D H Lowenstein; D A Butler; D Westaway; M P McKinley; S J DeArmond; S B Prusiner
Journal:  Mol Cell Biol       Date:  1990-03       Impact factor: 4.272

6.  Strain fidelity of chronic wasting disease upon murine adaptation.

Authors:  Christina J Sigurdson; Giuseppe Manco; Petra Schwarz; Pawel Liberski; Edward A Hoover; Simone Hornemann; Magdalini Polymenidou; Michael W Miller; Markus Glatzel; Adriano Aguzzi
Journal:  J Virol       Date:  2006-10-04       Impact factor: 5.103

7.  A prion-like protein from chicken brain copurifies with an acetylcholine receptor-inducing activity.

Authors:  D A Harris; D L Falls; F A Johnson; G D Fischbach
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

8.  Prion protein: evolution caught en route.

Authors:  P Tompa; G E Tusnády; M Cserzo; I Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

Review 9.  More than Just a Phase: Prions at the Crossroads of Epigenetic Inheritance and Evolutionary Change.

Authors:  Anupam K Chakravarty; Daniel F Jarosz
Journal:  J Mol Biol       Date:  2018-07-19       Impact factor: 5.469

10.  Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11 kd fragment of prion protein with an N-terminal glycine at codon 58.

Authors:  F Tagliavini; F Prelli; J Ghiso; O Bugiani; D Serban; S B Prusiner; M R Farlow; B Ghetti; B Frangione
Journal:  EMBO J       Date:  1991-03       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.